2020 CanVasc共识建议:抗中性粒细胞胞浆抗体相关性血管炎的管理(更新版)

2020-09-15 J Rheumatol . 2020 Sep 15.

2020年9月,加拿大血管炎研究网络更新发布了抗中性粒细胞胞浆抗体相关性血管炎的管理建议,本文是对2015年版管理建议的更新,共提出了11条新的推荐意见和16条修订意见,保留了2015版管理建议中的1

中文标题:

2020 CanVasc共识建议:抗中性粒细胞胞浆抗体相关性血管炎的管理(更新版)

英文标题:

CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update

发布机构:

发布日期:

2020-09-15

简要介绍:

2020年9月,加拿大血管炎研究网络更新发布了抗中性粒细胞胞浆抗体相关性血管炎的管理建议,本文是对2015年版管理建议的更新,共提出了11条新的推荐意见和16条修订意见,保留了2015版管理建议中的12条建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 CanVasc共识建议:抗中性粒细胞胞浆抗体相关性血管炎的管理(更新版.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b46c61c0019e90c6, title=2020 CanVasc共识建议:抗中性粒细胞胞浆抗体相关性血管炎的管理(更新版), enTitle=CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update, guiderFrom=J Rheumatol . 2020 Sep 15., authorId=0, author=, summary=2020年9月,加拿大血管炎研究网络更新发布了抗中性粒细胞胞浆抗体相关性血管炎的管理建议,本文是对2015年版管理建议的更新,共提出了11条新的推荐意见和16条修订意见,保留了2015版管理建议中的1, cover=https://img.medsci.cn/2020928/1601308649440_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Sep 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年9月,加拿大血管炎研究网络更新发布了抗中性粒细胞胞浆抗体相关性血管炎的管理建议,本文是对2015年版管理建议的更新,共提出了11条新的推荐意见和16条修订意见,保留了2015版管理建议中的12条建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=38709, tagName=抗中性粒细胞胞浆抗体), TagDto(tagId=74160, tagName=抗中性粒细胞胞浆抗体相关血管炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=38709, guiderKeyword=抗中性粒细胞胞浆抗体, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6228, appHits=363, showAppHits=0, pcHits=619, showPcHits=5865, likes=3, shares=19, comments=10, approvalStatus=1, publishedTime=Tue Sep 29 00:24:45 CST 2020, publishedTimeString=2020-09-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Sep 28 23:57:44 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 20:55:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 CanVasc共识建议:抗中性粒细胞胞浆抗体相关性血管炎的管理(更新版.pdf)])
2020 CanVasc共识建议:抗中性粒细胞胞浆抗体相关性血管炎的管理(更新版.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051903, encodeId=f9851051903cf, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:54:00 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998652, encodeId=4d7d998652ea, content=不错,有指导意义。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73071363416, createdName=lizhong20007980, createdTime=Sun Jul 11 22:15:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963021, encodeId=a759963021b4, content=怎么转成中文呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:49:22 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963015, encodeId=24f8963015bc, content=学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:39:01 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908877, encodeId=3c739088e753, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/7bf148a132894e31ad4b57e016bc4707/6d80ea5359cb4480a309f37615d5289a.jpg, createdBy=60915428052, createdName=ms6000000325781995, createdTime=Thu Dec 17 16:35:04 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051903, encodeId=f9851051903cf, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:54:00 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998652, encodeId=4d7d998652ea, content=不错,有指导意义。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73071363416, createdName=lizhong20007980, createdTime=Sun Jul 11 22:15:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963021, encodeId=a759963021b4, content=怎么转成中文呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:49:22 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963015, encodeId=24f8963015bc, content=学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:39:01 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908877, encodeId=3c739088e753, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/7bf148a132894e31ad4b57e016bc4707/6d80ea5359cb4480a309f37615d5289a.jpg, createdBy=60915428052, createdName=ms6000000325781995, createdTime=Thu Dec 17 16:35:04 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-07-11 lizhong20007980

    不错,有指导意义。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051903, encodeId=f9851051903cf, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:54:00 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998652, encodeId=4d7d998652ea, content=不错,有指导意义。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73071363416, createdName=lizhong20007980, createdTime=Sun Jul 11 22:15:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963021, encodeId=a759963021b4, content=怎么转成中文呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:49:22 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963015, encodeId=24f8963015bc, content=学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:39:01 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908877, encodeId=3c739088e753, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/7bf148a132894e31ad4b57e016bc4707/6d80ea5359cb4480a309f37615d5289a.jpg, createdBy=60915428052, createdName=ms6000000325781995, createdTime=Thu Dec 17 16:35:04 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-05-06 莫朵朵

    怎么转成中文呢?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051903, encodeId=f9851051903cf, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:54:00 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998652, encodeId=4d7d998652ea, content=不错,有指导意义。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73071363416, createdName=lizhong20007980, createdTime=Sun Jul 11 22:15:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963021, encodeId=a759963021b4, content=怎么转成中文呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:49:22 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963015, encodeId=24f8963015bc, content=学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:39:01 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908877, encodeId=3c739088e753, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/7bf148a132894e31ad4b57e016bc4707/6d80ea5359cb4480a309f37615d5289a.jpg, createdBy=60915428052, createdName=ms6000000325781995, createdTime=Thu Dec 17 16:35:04 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2021-05-06 莫朵朵

    学习学习!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1051903, encodeId=f9851051903cf, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:54:00 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998652, encodeId=4d7d998652ea, content=不错,有指导意义。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73071363416, createdName=lizhong20007980, createdTime=Sun Jul 11 22:15:41 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963021, encodeId=a759963021b4, content=怎么转成中文呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:49:22 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963015, encodeId=24f8963015bc, content=学习学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092f5488630, createdName=莫朵朵, createdTime=Thu May 06 10:39:01 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908877, encodeId=3c739088e753, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201217/7bf148a132894e31ad4b57e016bc4707/6d80ea5359cb4480a309f37615d5289a.jpg, createdBy=60915428052, createdName=ms6000000325781995, createdTime=Thu Dec 17 16:35:04 CST 2020, time=2020-12-17, status=1, ipAttribution=)]
    2020-12-17 ms6000000325781995

    学习学习

    0

拓展阅读

2021 ACR/VF指南:抗中性粒细胞胞浆抗体相关性血管炎的治疗

美国风湿病学会(ACR,American College of Rheumatology) · 2021-07-08